ICON plc, a global provider of drug development and commercialization services, announced that its Accellacare Site Network has entered new partnerships with six research sites across four countries, expanding its global footprint and capabilities.   Agreements with Asclepes Research and Olympian Clinical Research in the U.S., Curiositas ad Sanum and Intermed in Germany, Quironsalud in Spain, and KO-MED in Poland brings the Accellacare network to 112 active locations across eight countries and...